biotechnology

  • Bio
    Genalyte raises $36 million from Khosla for its one-drop blood test

    Genalyte raises $36 million from Khosla for its one-drop blood test

    Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group. The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 different tests on a single finger prick of blood in under 15 minutes using what it calls its Maverick Detection Platform. Genalyte’s proprietary… Read More

  • Bio
    Chinese scientists CRISPR a human for the first time

    Chinese scientists CRISPR a human for the first time

    A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it’s encouraged a biomedical battle between China and the United States. The scientists from China are hoping the genetically edited cells will help their patient fend off a virulent type of… Read More

  • Bio
    Genetics startup Genos wants to pay you for your DNA data

    Genetics startup Genos wants to pay you for your DNA data

    The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since then, leading to a new breed of consumer genetics startups taking a deeper dive into all the double helix’s that make up you. Genos is one of those startups using a next-generation… Read More

  • Bio
    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    There are a lot of startups looking at your DNA these days but uBiome stands out as unique among them for testing the DNA of microorganisms found in your fecal matter. These bugs have a lot to do with your health and the startup is launching a clinical screening test called SmartGut to sequence the DNA of those microbes. uBiome tells TechCrunch it has also closed on $15.5 million in Series… Read More

  • Bio
    Jeff Bezos, Mayo Clinic back anti-aging startup Unity Biotechnology for $116 million

    Jeff Bezos, Mayo Clinic back anti-aging startup Unity Biotechnology for $116 million

    Every once in a while someone in Silicon Valley brings up the possibility of living forever, or at least a really long time, but first we’re going to need to figure out a way to enjoy all those extra years. Unity Biotechnology is a startup focusing on medicines to help us do that by slowing the effects of age-related diseases. And the company announced it has pulled in a whopping… Read More

  • 23andMe reportedly no longer working on next-gen sequencing

    23andMe reportedly no longer working on next-gen sequencing

    23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-based lab, according to BuzzFeed, which first reported the news. By our own count based on LinkedIn, at least five members of the lab have been let go, including its chief medical officer, Dr. Read More

  • Bio
    Scientists made babies from mouse skin cells

    Scientists made babies from mouse skin cells

    A group of Japanese scientists from Kyushu University has successfully turned mouse skin cells into baby mice without the use of egg cells. The technology skips over the usual method of fertilizing egg cells with sperm and instead uses a method to grow the cells with the necessary chromosomal pairs needed for life to begin. This is the first time something like this has ever been achieved… Read More

  • Bio
    Biotech startup Zymergen nabs $130 million from Softbank

    Biotech startup Zymergen nabs $130 million from Softbank

    Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes crazy new materials out of genetically altered microbes. It was busy buying up a bunch of robots to make these microbes for mass production of various materials during its last round of funding. CEO… Read More

  • The biotech empires of Silicon Valley and Europe Crunch Network

    The biotech empires of Silicon Valley and Europe

    As biotechnology gains prominence among investors, two hubs have emerged as hotbeds of innovation for the resurgent industry. While the two-square-mile patch of South San Francisco bustles with more than 70 biotech firms, including Genentech, Amgen and Exelixis, an equally influential geography has grown along the Lemanic Arc of Switzerland and into the heart of Basel, where pharma… Read More

  • Bio
    A federal safety board just OK’d the first CRISPR trial to genetically alter humans

    A federal safety board just OK’d the first CRISPR trial to genetically alter humans

    In the spring of 2015, a group of Chinese scientists modified the DNA of 54 embryos using CRISPR/Cas 9 technology. Twenty-eight of those embryos were successful, but 26 — nearly half of them — failed, setting off a heated debate throughout the scientific community on the ethics of altering human genes. Regulators don’t currently allow the use of CRISPR on human DNA in the… Read More